Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-17

Clinical Trial Update: Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether oral curcumin supplementation improves insulin sensitivity in adults with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Hospital General de México Dr. Eduardo Liceaga | Conditions: PreDiabetes | Phase 4 | Status: UNKNOWN